C-erb-B2 research in breast cancer


 

The anti-c-erb-B2 antibody is fixed on the membrane receptor,
giving a clear delineation of positive cancer cells,
which should respond to trastuzumab treatment.

 
(Picture courtesy of the Pathology Unit
Centre François Baclesse - Dr Denoux)
 
 
Acces to main course